Features Pricing Learn Reverse Splits Tracker Shelf & ATM Tracker Warrant Tracker PIPE Deal Tracker Weekly Report FAQ API Sign In →
76 /100
COMPONENT-LIMITED
Score updated Nov 20, 2026

APVO — Aptevo Therapeutics Inc. Dilution Risk Tracker

Track APVO dilution risk with DilutionWatch's stock tracker. DilutionScore™ measures dilution risk across 5 factors — higher scores indicate higher risk of share dilution.

Not financial advice. Do your own research before making any investment decisions.

Track APVO — Get alerts when the score changes →

As of November 20, 2026, Aptevo Therapeutics Inc. (APVO) has a DilutionWatch DilutionScore of 76/100, rated CRITICAL dilution risk. This is a component-limited score because one or more material inputs are unavailable or not applicable. Aptevo Therapeutics Inc. has a market capitalization of $1.43M, 3.46M shares outstanding, 12 institutional holders tracked. Stored dilution-related fields include ATM program capacity of $2.31M, 6.06M outstanding warrants.

This page includes automatically generated factual summaries from DilutionWatch data. It is not financial advice, not investment research, and not a recommendation. Do your own research. Read the full disclaimer and terms of service.

Score Breakdown

Offering Ability
80
Cash Runway
40
Float Risk—
Warrant Exposure
90
Convertible Debt
40

Dilution Forecast

Forecast data not available for this ticker.

Market Data

Market Cap$1.43M
Shares Outstanding3.46M
Float935.4K
Cash$17.46M
Debt$3.46M
Short InterestN/A

Source-Backed Evidence Depth

This public preview uses stored DilutionWatch fields and linked SEC/market records only. Missing values are not estimated.

FieldCurrent ValueBasis
DilutionScore76/100DilutionWatch score record
Shares Outstanding3.46MVerified float table or market cache
Public Float935.4KVerified float table or market cache
Market Cap$1.43MMarket data cache
Cash Runway12.6 monthsDilutionWatch score inputs
Shelf CapacityNone in current score inputsSEC-derived dilution fields
ATM Capacity$2.31MSEC-derived dilution fields
Outstanding Warrants6.06MSEC-derived dilution fields

Recent source-backed SEC insight records available on this page: 6.

Recent SEC source mix: 424B5 1, 8-K 3, S-1 1, XBRL 1.

The page does not infer future share issuance, financing probability, cash needs, management intent, or price impact when source fields are absent.

APVO SEC Filing Activity — Last 12 Months

Shares outstanding reported by APVO on the cover page of its latest 10-K/10-Q: 3.46M as of November 16, 2026.

DilutionWatch recorded 2 registration or prospectus documents for APVO (the filings through which shares are offered) in the last 12 months. Full filing list on SEC EDGAR →

FormWhat it isFilingsMost recent
S-1registration statement (IPO / follow-on)1Nov 20, 2026
424B5prospectus supplement (ATM / shelf takedown)1Oct 30, 2026
8-Kcurrent report (material event)6Nov 16, 2026
10-Qquarterly report1Nov 16, 2026
SC 13G/Aamended passive >5% holder filing2Nov 16, 2026

Institutional Holdings

12 institutional holders · 497.2K shares
#1 Point72 Asset Management, L.P. 299.9K shares
#2 DRW Securities, LLC 131.5K shares
#3 Virtu Financial LLC 38.3K shares
+ 9 more holders Sign up free to view →

Institutional holder totals are aggregated from ownership filings and may use a different share basis or reporting date than public float. They are not a reconciliation against tradeable float.

Short Interest

Short Interest71.3K
Days to Cover1.9
% of Float7.6%
FINRA data as of Oct 30, 2026

Recent SEC Activity

xbrl XBRL WARRANT 2026-11-16
S-1 SHELF 2026-11-20
8-K 8K EVENT 2026-11-12
8-K 8K EVENT 2026-11-02
424B5 ATM 2026-10-30
Full SEC filing analysis available with free account →

Recent News

No recent news available for this ticker.

Factual APVO Dilution Snapshot

Aptevo Therapeutics Inc. (APVO) has a DilutionScore of 76/100, rated Critical dilution risk. Score date: November 20, 2026.

This automatically generated snapshot is assembled from stored DilutionWatch data fields and may contain data-source errors or omissions. It is not financial advice, not investment research, and not a recommendation. Do your own research and review the full disclaimer and terms of service.

DilutionScore History — Last 90 Days

APVO's DilutionScore is currently 76/100 (Critical risk), with 2 score changes tracked over 89 days. The score improved from 63/100 (High risk).

Period Score Risk Level Duration
Nov 20, 202676/100CRITICAL1 day
Oct 05 – Nov 19, 202663/100HIGH46 days
Aug 24 – Oct 04, 202641/100MEDIUM42 days

Score recalculated daily from SEC filings and market data. Sign up free for real-time score change alerts.

Share Dilution History

APVO shares outstanding have increased 92.3% from 1.80M (Nov 2026) to 3.46M (Nov 2026). Each increase represents potential dilution to existing shareholders.

Date Shares Outstanding Public Float Change
Nov 21, 20263.46M935.4K—
Nov 17, 20263.46M935.4K—
Nov 10, 20261.80M935.4K—

Share counts sourced from verified regulatory filings. Increases indicate dilution events.

Track APVO Dilution Risk in Real-Time
DilutionWatch monitors SEC filings 24/7 and alerts you the moment APVO files a shelf registration, ATM offering, warrant notice, or convertible note. Free tier available — no credit card required.
Start Tracking APVO — Free
Email alert within minutes of any SEC filing Daily DilutionScore™ recalculation Score history & trend tracking Tracks 8,000+ tickers simultaneously

Related Stocks — CRITICAL Risk

Other CRITICAL dilution risk stocks tracked by DilutionWatch with similar profiles:

→ Biotech / Pharma sector dilution risk overview

Browse all 7,727+ tracked stocks →

Dilution Education
→ Complete Dilution Guide for Retail Investors → Anti-Dilution Provisions Explained → Stock Dilution Red Flags to Watch → Understanding Shelf Registrations

Score Coverage Note

More Research for APVO
APVO FDA Catalyst Timeline & Biotech Grade — BiotechSigns

Part of the Guerilla Finance research network. Cross-reference multiple data sources for better due diligence.